[Phe1Ψ(CH2-NH)GLY2]-nociceptin-(1-13)NH2, proposed antagonist of the nociceptin receptor, is a potent and stable agonist in the rat spinal cord

Neuroscience Letters

Volumn 249, Issue 2-3, 1998, Pages 127-130

  Xu, Isabella S ^a   Wiesenfeld Hallin, Zsuzsanna ^a   Xu, Xiao Jun ^a  

^a Div Clin Neurophysiol   (Sweden)

Author keywords

Antinociception; Flevor reflex; Nociceptin; Orphanin FQ; Pain; Spinal cord

Indexed keywords

ANTINOCICEPTIVE AGENT; NOCICEPTIN; NOCICEPTIN (1 13) NH2, PHE(1) PSI(CH2 NH) GLY(2); NOCICEPTIN (1-13)-NH2, PHE(1)-PSI(CH2-NH)-GLY(2)-; NOCICEPTIN RECEPTOR; OPIATE PEPTIDE; OPIATE RECEPTOR; PEPTIDE FRAGMENT;

ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; ENZYME DEGRADATION; FLEXOR REFLEX; NOCICEPTION; NONHUMAN; PAIN; PRIORITY JOURNAL; RAT; SPINAL CORD; ANIMAL; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; FEMALE; INTRASPINAL DRUG ADMINISTRATION; REFLEX; SPRAGUE DAWLEY RAT; TIME;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; INJECTIONS, SPINAL; OPIOID PEPTIDES; PEPTIDE FRAGMENTS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID; REFLEX; SPINAL CORD; TIME FACTORS;

EID: 0032546651     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(98)00411-X     Document Type: Article

References (20)

1. Bunzow J.R., Saez C., Mortrud M., Bouvier C., Williams J.T., Low M., Grandy D.K. Molecular cloning and tissue distribution of a putative member of the rat opioid receptor gene family that is not a μ, δ or κ receptor type. FEBS Lett. 347:1994;284-288.
2. Erb K., Liebel J.T., Teaeder I., Zeilhofer H.U., Brune K., Geisslinger G. Spinally delivered nociceptin/orphanin FQ reduces flinching behaviour in the rat formalin test. NeuroReport. 8:1997;1967-1970.
3. Faber E.S.L., Chambers J.P., Evans R.H., Henderson G. Depression of glutamatergic transmission by nociceptin in the neonatal rat hemisected spinal cord preparation in vitro. Br. J. Pharmacol. 119:1996;189-190.
4. Guerrini R., Calo G., Rizzi A., Bigono R., Bianchi C., Salvadori S., Regoli D. A new selective antagonist of the nociceptin receptor. Br. J. Pharmacol. 123:1998;163-165.
5. Hara N., Minami T., Okuda-Ashitaka E., Sugimoto T., Sakai M., Onaka M., Mori H., Imanishi T., Shingu K., Ito S. Characterization of nociceptin hyperalgesia and allodynia in conscious mice. Br. J. Pharmacol. 121:1997;401-408.
6. Henderson G., McKnight A.T. The orphan opioid receptor and its endogenous ligand-nociceptin/orphanin FQ. Trends Pharmacol. Sci. 18:1997;293-300.
7. King M.A., Rossi G.C., Chang A.H., Williams L., Pasternak G.W. Spinal analgesic activity of orphanin FQ/nociceptin and its fragments. Neurosci. Lett. 223:1997;113-116.
8. Lai C.C., Wu S.Y., Dun S.L., Dun N.J. Nociceptin-like immunoreactivity in the rat dorsal horn and inhibition of substantia gelatinosa neurons. Neuroscience. 81:1997;887-891.
9. Liebel J.T., Swandulla D., Zeilhofer H.U. Modulation of excitatory synaptic transmission by orphanin FQ in superficial dorsal horn neurones of the neonatal rat spinal cord. Br. J. Pharmacol. 121:1997;425-432.
10. Meunier J.-C., Mollereau C., Toll L., Suaudeau C., Moisand C., Alvinerie P., Butour J.-L., Guillemot J.-C., Ferrara P., Monsarrat B., Mazarguil H., Vassart G., Parmentier M., Costentin J. Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor. Nature. 377:1995;532-535.
11. Mogil J.S., Grisel J.E., Reinscheid R.K., Civelli O., Belknap J.K., Grandy D.K. Orphanin FQ is a functional anti-opioid peptide. Neuroscience. 75:1996;333-337.
12. Montiel J.L., Cornille F., Roques B.P., Noble F. Nociceptin/orphanin FQ metabolism: role of aminopeptidase and endopeptidase 24.15. J. Neurochem. 68:1997;354-361.
13. Reinscheid R.K., Nothacker H.-P., Bourson A., Ardati A., Henningsen R.A., Bunzow J.R., Grandy D.K., Langen H., Monsma F.J., Civelli O. Orphanin FQ: a neuropeptide that activates an opioid-like G protein-coupled receptor. Science. 270:1995;792-794.
14. Riedl M., Shuster S., Vulchanova L., Wang J., Loh H.H., Elde R.P. Orphanin FQ/nociceptin-immunoreactive nerve fibers parallel those containing endogenous opioids in rat spinal cord. NeuroReport. 7:1996;1369-1372.
15. Rossi G.C., Leventhal L., Pasternak G.W. Naloxone sensitive nociceptin-induced analgesia in mice. Eur. J. Pharmacol. 311:1996;R7-R8.
16. Schuligoi R., Amann R., Angelberger P., Peskar B.A. Determination of nociceptin-like immunoreactivity in the rat spinal cord. Neurosci. Lett. 224:1997;136-138.
17. Stanfa L.C., Chapman V., Kerr N., Dickenson A.H. Inhibitory action of nociceptin on spinal dorsal horn neurones of the rat in vivo. Br. J. Pharmacol. 118:1996;1875-1877.
18. Tian J.-H., Xu W., Fang Y., Mogil J.S., Grisel J.E., Grandy D.K., Han J.-S. Bidirectional modulatory effect of orphanin FQ on morphine-induced analgesia: antagonism in brain and potentiation in spinal cord of the rat. Br. J. Pharmacol. 120:1997;676-680.
19. Wang X.-M., Zhang K.M., Mokha S.S. Nociceptin (orphanin FQ), an endogenous ligand for the ORL1 (opioid-receptor-like 1) receptor, modulates responses of trigeminal neurons evoked by excitatory amino acids and somatosensory stimuli. J. Neurophysiol. 76:1996;3568-3572.
20. Xu X.-J., Hao J.-X., Wiesenfeld-Hallin Z. Nociceptin or antinociceptin: potent spinal antinociceptive effect of orphanin FQ/nociceptin in the rat. NeuroReport. 7:1996;2092-2094.